{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:57:22Z","timestamp":1788375442500,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijid.2022.12.015","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:03:52Z","timestamp":1671159832000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The efficacy and safety of a shortened duration of antimicrobial therapy for group A Streptococcus bacteremia"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-6549","authenticated-orcid":false,"given":"Andrew D.K.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-3738","authenticated-orcid":false,"given":"Simon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-2764","authenticated-orcid":false,"given":"Trent","family":"Yarwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-3839","authenticated-orcid":false,"given":"Josh","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.12.015_bib0023","first-page":"603","article-title":"Streptococcus pyogenes bacteraemia in Cambridge\u2013a review of 67 episodes","volume":"68","author":"Francis","year":"1988","journal-title":"Q J Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006577","article-title":"The role of social determinants of health in the risk and prevention of Group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: s systematic review","volume":"12","author":"Coffey","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/tmi.12405","article-title":"Changes in the clinical and epidemiological features of Group A streptococcal bacteraemia in Australia's Northern Territory","volume":"20","author":"Gear","year":"2015","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2022.12.015_bib0004","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4269\/ajtmh.20-0846","article-title":"Echocardiographic screening detects a significant burden of rheumatic heart disease in Australian Torres Strait Islander children and missed opportunities for its prevention","volume":"104","author":"Hempenstall","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2022.12.015_sbref0005","first-page":"148","article-title":"Invasive Group A streptococcal disease in North Queensland (1996\u20132001)","volume":"119","author":"Norton","year":"2004","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2022.12.015_bib0006","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive Group A streptococcal infections in the United States, 2005\u20132012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_sbref0007","first-page":"367","article-title":"Group A streptococcal bacteremia: outcome and prognostic factors","volume":"19","author":"Vallalta Morales","year":"2006","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijid.2022.12.015_bib0008","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10096-020-03851-6","article-title":"Group A streptococcal bacteremias in Southwest Finland 2007\u20132018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection","volume":"39","author":"Vilhonen","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0009","series-title":"Directed Therapy for Bloodstream Infections, Including Sepsis and Septic Shock","year":"2022"},{"key":"10.1016\/j.ijid.2022.12.015_bib0010","series-title":"The Management of Invasive Group A Streptococcal Infections in Ireland","year":"2006"},{"key":"10.1016\/j.ijid.2022.12.015_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijid.2022.12.015_bib0012","unstructured":"Stevens DL. Invasive Group A Streptococcal infection and toxic shock syndrome: treatment and prevention Edwards MS, Wessels MR, editors. Waltham: UpToDate, 2022. p. 2021."},{"key":"10.1016\/j.ijid.2022.12.015_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmi.2019.05.012","article-title":"Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections","volume":"26","author":"Al-Hasan","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2022.12.015_bib0014","doi-asserted-by":"crossref","first-page":"e01515","DOI":"10.1128\/AAC.01515-20","article-title":"Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated Streptococcal bloodstream infections","volume":"64","author":"Arensman","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.12.015_bib0015","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1093\/ofid\/ofy210.838","article-title":"1001. Evaluation of the clinical efficacy and safety of oral antibiotic therapy for Streptococcus spp. Bloodstream infections","volume":"5","author":"Kang","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archinte.161.6.848","article-title":"Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia","volume":"161","author":"Ramirez","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0017","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S1473-3099(20)30602-2","article-title":"To give or not to give antibiotics is not the only question","volume":"21","author":"Magalh\u00e3es","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0018","unstructured":"The European Committee on Antimicrobial Susceptibility Testing \u2013EUCAST. Clinical breakpoints - breakpoints and guidance, https:\/\/www.eucast.org\/clinical_breakpoints\/; 2022 (accessed 25 May 2022)."},{"key":"10.1016\/j.ijid.2022.12.015_bib0019","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0021","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group Severe Streptococcal Infections","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2022.12.015_bib0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18773\/austprescr.2019.065","article-title":"Penicillin allergy: a practical approach to assessment and prescribing","volume":"42","author":"Devchand","year":"2019","journal-title":"Aust Prescr"},{"key":"10.1016\/j.ijid.2022.12.015_bib0001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive Group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004","volume":"45","author":"O'Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0024","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.163.4.467","article-title":"Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario","volume":"163","author":"Muller","year":"2003","journal-title":"Canada. Arch Intern Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0025","series-title":"Commonwealth of Australia","year":"2020"},{"key":"10.1016\/j.ijid.2022.12.015_bib0026","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archinte.159.6.607","article-title":"Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis","volume":"159","author":"Olaison","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000356.pub3","article-title":"Early discharge hospital at home","volume":"2009","author":"Shepperd","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2022.12.015_bib0028","article-title":"Delayed antibiotic prescriptions for respiratory infections","volume":"9","author":"Spurling","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2022.12.015_bib0029","doi-asserted-by":"crossref","first-page":"l5337","DOI":"10.1136\/bmj.l5337","article-title":"Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by Group A streptococci: randomised controlled, open label, non-inferiority study","volume":"367","author":"Skoog St\u00e5hlgren","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2022.12.015_bib0030","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0031","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/cid\/ciab201","article-title":"Comparable outcomes of short-course and prolonged-course therapy in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia: a pooled cohort study","volume":"73","author":"Thorlacius-Ussing","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0032","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0033","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial Oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jcpt.13277","article-title":"Short-course versus long-course antibiotic treatment in patients with uncomplicated gram-negative bacteremia: a systematic review and meta-analysis","volume":"46","author":"Li","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijid.2022.12.015_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0036","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCRESAHA.119.315279","article-title":"Duration and life-stage of antibiotic use and risks of all-cause and cause-specific mortality: prospective cohort study","volume":"126","author":"Heianza","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.ijid.2022.12.015_bib0037","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2022.12.015_bib0038","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2958.1993.tb01723.x","article-title":"Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae","volume":"9","author":"Dowson","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijid.2022.12.015_bib0039","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.00851-06","article-title":"Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.12.015_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature12212","article-title":"Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome","volume":"499","author":"Modi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2022.12.015_bib0041","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. Finnish study group for antimicrobial resistance","volume":"337","author":"Sepp\u00e4l\u00e4","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0042","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity","volume":"163","author":"Hecker","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0043","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CCM.0b013e3181fa41a7","article-title":"Inappropriate antibiotic therapy in gram-negative sepsis increases hospital length of stay","volume":"39","author":"Shorr","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2022.12.015_bib0044","first-page":"923","article-title":"Appropriate antibiotic use reduces length of hospital stay","volume":"72","author":"van den Bosch","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2022.12.015_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1049909119855617","article-title":"Increased length of stay associated with antibiotic use in older adults with advanced cancer transitioned to comfort measures","volume":"37","author":"Datta","year":"2020","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.ijid.2022.12.015_bib0046","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1186\/s12913-021-06880-9","article-title":"I'm outta here!\": a qualitative investigation into why Aboriginal and non-Aboriginal people self-discharge from hospital","volume":"21","author":"Askew","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ijid.2022.12.015_bib0047","unstructured":"Australia Institute of Health and Welfare. Australia's health 2018, https:\/\/www.aihw.gov.au\/reports\/australias-health\/australias-health-2018\/contents\/overview; 2018 [accessed 29 June 2022]."},{"key":"10.1016\/j.ijid.2022.12.015_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008990","article-title":"The temporospatial epidemiology of rheumatic heart disease in Far North Queensland, tropical Australia 1997\u20132017; impact of socioeconomic status on disease burden, severity and access to care","volume":"15","author":"Kang","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0049","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1742-6723.13559","article-title":"Aeromedical retrievals in Queensland: a five-year review","volume":"33","author":"Franklin","year":"2021","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.ijid.2022.12.015_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S2055-6640(20)30270-3","article-title":"A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia","volume":"4","author":"Lee","year":"2018","journal-title":"J Virus Erad"},{"key":"10.1016\/j.ijid.2022.12.015_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007929","article-title":"Severe leptospirosis in tropical Australia: optimising intensive care unit management to reduce mortality","volume":"13","author":"Smith","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005411","article-title":"The epidemiology and clinical features of melioidosis in Far North Queensland: implications for patient management","volume":"11","author":"Stewart","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0053","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments","volume":"51","author":"Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.12.015_bib0054","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","article-title":"Effectiveness of adjunctive clindamycin in beta-lactam antibiotic-treated patients with invasive beta-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study","volume":"21","author":"Babiker","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2022.12.015_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.697938","article-title":"Invasive Group A streptococcal infections: benefit of clindamycin, intravenous immunoglobulins and secondary prophylaxis","volume":"9","author":"Laho","year":"2021","journal-title":"Front Pediatr"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222006506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222006506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:09:41Z","timestamp":1761120581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222006506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":55,"alternative-id":["S1201971222006506"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.12.015","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of a shortened duration of antimicrobial therapy for group A Streptococcus bacteremia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}